538P Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC) - Awada, A.H.; Zematis, M.; Ochsenreither, S.; Eefsen, R.L.; Arnold, D.; Cicenas, S.; Yachnin, J.; Pfeiffer, P.; Paz-Ares, L.; Jungels, C.; Greil, R.; Poulsen, L. Østergaard; et al. (Annals of oncology, 2021)